Assess Neonatal Abstinence Syndrome (NAS) severity.
Loading...
Found this tool helpful? Share it with your friends!
The Finnegan Score is a standardized clinical assessment tool designed to quantify the severity of Neonatal Abstinence Syndrome (NAS). It is primarily utilized by healthcare professionals, including neonatologists, pediatricians, and nurses, to evaluate signs and symptoms in neonates exposed to opioids or other substances in utero. This scoring system assigns points across various physiological and neurological categories, such as central nervous system irritation, metabolic instability, and gastrointestinal dysfunction. By providing an objective and consistent measure of withdrawal severity, the Finnegan Score is instrumental in guiding pharmacological intervention decisions, monitoring treatment effectiveness, and optimizing care pathways to improve outcomes for affected infants.
Clinical tools to assess the severity of drug and alcohol withdrawal syndromes.